Insider Selling: Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Sells 48,711 Shares of Stock

Anteris Technologies Global Corp. (NASDAQ:AVRGet Free Report) major shareholder L1 Capital Pty Ltd sold 48,711 shares of the stock in a transaction on Friday, July 31st. The shares were sold at an average price of $8.15, for a total transaction of $396,994.65. Following the completion of the transaction, the insider owned 6,584,603 shares of the company’s stock, valued at approximately $53,664,514.45. This represents a 0.73% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

  • On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total transaction of $3,853,113.30.
  • On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.04, for a total value of $1,250,260.20.
  • On Thursday, July 30th, L1 Capital Pty Ltd sold 558,633 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.20, for a total value of $4,580,790.60.
  • On Monday, July 27th, L1 Capital Pty Ltd sold 232,817 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.19, for a total value of $1,906,771.23.
  • On Tuesday, July 28th, L1 Capital Pty Ltd sold 208,731 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.09, for a total transaction of $1,688,633.79.
  • On Friday, July 24th, L1 Capital Pty Ltd sold 23,000 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.13, for a total transaction of $186,990.00.

Anteris Technologies Global Stock Performance

AVR opened at $8.28 on Tuesday. The firm has a market cap of $805.99 million, a price-to-earnings ratio of -3.71 and a beta of 1.65. The firm’s 50-day simple moving average is $9.19 and its 200-day simple moving average is $7.19. Anteris Technologies Global Corp. has a twelve month low of $3.09 and a twelve month high of $11.06.

Anteris Technologies Global (NASDAQ:AVRGet Free Report) last announced its quarterly earnings results on Tuesday, May 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The firm had revenue of $0.49 million for the quarter, compared to the consensus estimate of $0.77 million. Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. During the same period in the prior year, the business earned ($0.61) earnings per share. As a group, sell-side analysts anticipate that Anteris Technologies Global Corp. will post -1.14 EPS for the current fiscal year.

Institutional Investors Weigh In On Anteris Technologies Global

A number of hedge funds have recently added to or reduced their stakes in the stock. L1 Capital Pty Ltd grew its holdings in Anteris Technologies Global by 143.2% during the 3rd quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company’s stock worth $30,772,000 after acquiring an additional 4,026,136 shares during the last quarter. ADAR1 Capital Management LLC raised its stake in shares of Anteris Technologies Global by 205.9% in the first quarter. ADAR1 Capital Management LLC now owns 3,789,132 shares of the company’s stock worth $21,030,000 after acquiring an additional 2,550,355 shares during the last quarter. Perceptive Advisors LLC raised its stake in shares of Anteris Technologies Global by 104.4% in the first quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock worth $19,011,000 after acquiring an additional 1,750,000 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Anteris Technologies Global by 9,958.6% during the second quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company’s stock worth $4,049,000 after purchasing an additional 1,057,707 shares in the last quarter. Finally, Militia Capital Management LLC acquired a new position in shares of Anteris Technologies Global during the first quarter worth approximately $3,663,000.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on AVR shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th. Barclays raised their price target on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Finally, Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Four investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Anteris Technologies Global has an average rating of “Moderate Buy” and an average price target of $16.00.

Get Our Latest Report on Anteris Technologies Global

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Recommended Stories

Insider Buying and Selling by Quarter for Anteris Technologies Global (NASDAQ:AVR)

Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.